Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Spaventa Insider Profile
4 Followers
Andrew Spaventa, CEO, Director at Singular Genomics Systems, holds 4.10M shares in Singular Genomics Systems (Ticker: OMIC).
Andrew Spaventa Singular Genomics Systems (OMIC)CEO, Director
Singular Genomics Systems (OMIC)
CEO, Director
Ranked #80,471 out of 98,624 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-45.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Andrew Spaventa's holdings
Insider Roles
CEO, Director
Roles that Andrew Spaventa holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew Spaventa
Andrew Spaventa's Trading History
List of latest transactions for each holding click on a transaction to see Andrew Spaventa's performance on stock
You May Also Like
Andrew Spaventa insider profile FAQ
What is the percentage of profitable transactions made by Andrew Spaventa?
The percentage of profitable transactions made by Andrew Spaventa is 0%.
What is the average return per transaction made by Andrew Spaventa?
The average return per transaction made by Andrew Spaventa is -45.10%.
What stocks does Andrew Spaventa hold?
Andrew Spaventa holds: OMIC stocks.
What was Andrew Spaventa’s latest transaction?
Andrew Spaventa latest transaction was an Uninformative Buy of ―.
What was Andrew Spaventa's most profitable transaction?
Andrew Spaventa’s most profitable transaction was an Informative Buy of OMIC stock on November 20, 2023. The return on the trade was -0.20%.
What is Andrew Spaventa's role in Singular Genomics Systems?
Andrew Spaventa's role in Singular Genomics Systems is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.